Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

BACKGROUND: Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53...

Descripción completa

Detalles Bibliográficos
Autores principales: Felisiak-Golabek, Anna, Rembiszewska, Alina, Rzepecka, Iwona K, Szafron, Lukasz, Madry, Radoslaw, Murawska, Magdalena, Napiorkowski, Tomasz, Sobiczewski, Piotr, Osuch, Beata, Kupryjanczyk, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223127/
https://www.ncbi.nlm.nih.gov/pubmed/22075440
http://dx.doi.org/10.1186/1757-2215-4-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223127/
https://www.ncbi.nlm.nih.gov/pubmed/22075440
http://dx.doi.org/10.1186/1757-2215-4-20

Ejemplares similares